Trademark: DYRUPEG 2282035
Word
DYRUPEG
ID
2282035
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
24 March 2022
Registration Date
24 March 2022
Renewal Date
24 March 2032
Owner(s)
Service
Goods and Services:
Class 5:
Injectable medicinal solutions used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils; medication used in the reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes); biopharmaceuticals; biological preparations for medical use; pharmaceutical preparations for medical use; pharmacological preparations for medical use; gene-based and cellular biologics for medical use; biochemical preparations for medical use; biosimilars for medical use; injectable pharmaceutical solutions for the prevention of infection in cancer patients; pharmaceutical; medical pharmaceuticals.
Injectable medicinal solutions used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils; medication used in the reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes); biopharmaceuticals; biological preparations for medical use; pharmaceutical preparations for medical use; pharmacological preparations for medical use; gene-based and cellular biologics for medical use; biochemical preparations for medical use; biosimilars for medical use; injectable pharmaceutical solutions for the prevention of infection in cancer patients; pharmaceutical; medical pharmaceuticals.